Just over a month before ACHEMA 2024 opens on 10 June, one thing is already clear: with more than 60% of exhibitors coming from abroad, this year's leading trade show for the global process industry will be the most international ACHEMA ever. Numerous side events from renowned partners await participants from 130 countries.

Just over a month before ACHEMA 2024 opens on 10 June, one thing is already clear: with more than 60 percent of exhibitors coming from abroad, this year's leading trade show for the global process industry will be the most international ACHEMA ever. Numerous side events from renowned partners await participants from 130 countries.

INTERPHEX, the premier, global pharmaceutical and biotechnology trade event concluded last week (April 16-18, 2024) following three days of scientifically curated discussions, daily networking events, and new product and innovative discovery.

10 May 2024 -- London, UK -- The curtain has closed on the debut London Biotechnology Show 2024, leaving attendees thoroughly impressed by the seamless delivery of promised content and exhibits. From massive exhibition to jam-packed conference sessions, from groundbreaking product launches to cutting-edge startup showcase, from insightful panel discussions to valuable networking opportunities.

7 May 2024 -- London, UK -- The most-awaited London Biotechnology Show will finally open its doors tomorrow at Olympia West, London, UK. #LBS24 is a 2 day conference & exhibition that will host an outstanding speaker line-up delivering insightful keynotes and world class exhibitors unveiling disruptive technologies and cutting-edge biotech solutions.

Drug Discovery 2024: Connecting Minds, Transforming Science, Empowering Community will take place at ExCeL London from 2–3 October

Beam expanders are used in CO2 laser systems to aid beam guidance over long distances and increase power density at the focal point. LASER COMPONENTS offer beam expanders composed of two ZnSe lenses, suitable up to medium power levels of 100W.

Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, today announced that Patrick Cushing PhD, has been promoted to vice president operations of Rentschler Biopharma, Inc., the company’s US subsidiary, effective 1 May 2024.

TechBio company Cytomos (www.cytomos.com) will be giving visitors to this year’s London Biotechnology Show a sneak preview of Celledonia – its flagship technology that utilises the company’s patented AuraCyt platform.

Dr Hooftman brings more than 25 years’ experience in international drug development including immunology, autoimmunity, hematology, oncology and infectious diseases.

Biopharma Group is hosting the 3rd edition of the popular freeze drying seminar series at the University of Cambridge. This year, the focus is on "Freeze Drying of In Vitro Diagnostics".

• Stable lentiviral (LV) cell line development service achieves unconcentrated titers >1E9 TU/mL for therapeutic transgenes. • Fully stable cell lines have all viral genes and transgene stably integrated, enabling biomanufacturing scalability and a more robust production process. • Transfection-free lentiviral manufacturing eliminates GMP plasmid cost and reduces supply chain risk for cell and gene therapy developers.